Cookies help us improve your ABPI online experience. If you accept their use, continue using our site. or, find out more about cookies.
International Policy Manager (Trade)
We are seeking an exceptional person to lead in the development and implementation of the ABPI’s trade policy agenda.
Apply now. Closing date 17 December 2021.
Invest and innovate to keep UK life sciences globally competitive
Richard Torbett outlines the case for investing in our sector ahead of the autumn's Comprehensive Spending Review.
ABPI publishes third annual report on UK clinical research
The ABPI's report calls for lessons from COVID-19 to be used to revitalise the post-pandemic clinical research environment.
ABPI 2021 Code of Practice
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
NICE/DSU/ABPI Virtual Masterclass: Optimising NICE submissions in oncology
NICE and the ABPI invite you to the third event in the NICE/DSU/ABPI Masterclass Programme for 2021 - Optimising NICE submissions in oncology.
ABPI & AAC ATMP Roadmap launch webinar
We are delighted to invite you to the launch of the brand new Accelerated Access Collaborative/ABPI Advanced Therapeutic Medicinal Products (ATMP) Roadmap.
Online Workshop on SMC: How to prepare and submit to SMC
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
We represent our members, using their insight and experience to tell the story of how they change the lives of millions of people every day.
Clinical trials are important for patients, they are beneficial to the NHS and they are good for the UK economy.
Clinical research in the UK: an opportunity for growth
Clinical trials are an essential part of the research and development (R&D) of new medicines and vaccines, bringing benefits to patients, the NHS and the economy.
Clinical trial transparency
Clinical trials are the cornerstone of the research and development process and it is through trials that pharmaceutical companies are able to demonstrate the safety and efficacy of new medicines.